Literature DB >> 19205034

Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization.

Nanette von Oppen1, Anna Schurich, Silke Hegenbarth, Dirk Stabenow, Rene Tolba, Ralf Weiskirchen, Albert Geerts, Waldemar Kolanus, Percy Knolle, Linda Diehl.   

Abstract

UNLABELLED: Peripheral CD8 T-cell tolerance can be generated outside lymphatic tissue in the liver, but the course of events leading to tolerogenic interaction of hepatic cell populations with circulating T-cells remain largely undefined. Here we demonstrate that preferential uptake of systemically circulating antigen by murine liver sinusoidal endothelial cells (LSECs), and not by other antigen-presenting cells in the liver or spleen, leads to cross-presentation on major histocompatibility complex (MHC) I molecules, which causes rapid antigen-specific naïve CD8 T-cell retention in the liver but not in other organs. Using bone-marrow chimeras and a novel transgenic mouse model (Tie2-H-2K(b) mice) with endothelial cell-specific MHC I expression, we provide evidence that cross-presentation by organ-resident and radiation-resistant LSECs in vivo was both essential and sufficient to cause antigen-specific retention of naïve CD8 T-cells under noninflammatory conditions. This was followed by sustained CD8 T-cell proliferation and expansion in vivo, but ultimately led to the development of T-cell tolerance.
CONCLUSION: Our results show that cross-presentation of circulating antigens by LSECs caused antigen-specific retention of naïve CD8 T-cells and identify antigen-specific T-cell adhesion as the first step in the induction of T-cell tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205034     DOI: 10.1002/hep.22795

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 2.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 3.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

4.  Podocytes are nonhematopoietic professional antigen-presenting cells.

Authors:  Andreas Goldwich; Miriam Burkard; Martha Olke; Christoph Daniel; Kerstin Amann; Christian Hugo; Christian Kurts; Alexander Steinkasserer; André Gessner
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

Review 5.  The liver works as a school to educate regulatory immune cells.

Authors:  Fenglei Li; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

6.  Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice.

Authors:  Miwa Morita; Daniel Joyce; Charles Miller; John J Fung; Lina Lu; Shiguang Qian
Journal:  Hepatology       Date:  2015-07-30       Impact factor: 17.425

Review 7.  Emerging roles of lymphatic endothelium in regulating adaptive immunity.

Authors:  Catherine M Card; Shann S Yu; Melody A Swartz
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

8.  Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells.

Authors:  Sachiko Hirosue; Efthymia Vokali; Vidya R Raghavan; Marcela Rincon-Restrepo; Amanda W Lund; Patricia Corthésy-Henrioud; Francesca Capotosti; Cornelia Halin Winter; Stéphanie Hugues; Melody A Swartz
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

Review 9.  Organ-specific differences in achieving tolerance.

Authors:  Maria Lucia L Madariaga; Daniel Kreisel; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 10.  Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Authors:  Elia Moreno-Cubero; Juan-Ramón Larrubia
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.